Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Solulin increases clot stability in whole blood from humans and dogs with hemophilia

Jonathan H. Foley, Karl-Uwe Petersen, Catherine J. Rea, Lori Harpell, Sandra Powell, David Lillicrap, Michael E. Nesheim, Benny Sørensen

Blood (2012) 119 (15): 3622–3628.

https://doi.org/10.1182/blood-2011-11-392308

Published: 2012

Journal Articles

The Role of Amino Acids 700–701 of the Factor Va Heavy Chain During Prothrombin Activation by Factor Xa

Jamila Hirbawi, PhD, Paul Y Kim, PhD, Michael E. Nesheim, PhD, Michael Kalafatis, PhD

Blood (2010) 116 (21): 2203.

https://doi.org/10.1182/blood.V116.21.2203.2203

Published: 2010

Journal Articles

The Kinetics of Activated Thrombin-Activatable Fibrinolysis Inhibitor with Respect to Plasminogen Binding Site Removal From Fibrin Degradation Products.

Jonathan H. Foley, B.Sc.H, Michael E. Nesheim, PhD

Blood (2009) 114 (22): 3185.

https://doi.org/10.1182/blood.V114.22.3185.3185

Published: 2009

Journal Articles

The Role of Lysine Residues 42, 43, and 44 in the Activation Peptide Region of TAFI in Its Activation by the Thrombin-Thrombomodulin Complex.

Chengliang Wu, M.Sc., Paul Y Kim, Ph.D., Reg Manuel, Ann Gils, Ph.D., Paul Declerck, Ph.D., Michael E. Nesheim, PhD

Blood (2009) 114 (22): 3187.

https://doi.org/10.1182/blood.V114.22.3187.3187

Published: 2009

Journal Articles

The Effects of Activated Protein C, Heparin, and Antithrombin On Thresholding Behaviour in Prothrombin Activation by Prothrombinase.

Michael P. Cook, M.Sc., Kate Colizza, B.Sc.H., Michael E. Nesheim, Ph.D.

Blood (2009) 114 (22): 2138.

https://doi.org/10.1182/blood.V114.22.2138.2138

Published: 2009

Journal Articles

Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis

Michael B. Boffa, Deborah Maret, Jeffrey D. Hamill, Nazareth Bastajian, Paul Crainich, Nancy S. Jenny, Zhonghua Tang, Elizabeth M. Macy, Russell P. Tracy, Rendrik F. Franco, Michael E. Nesheim, Marlys L. Koschinsky

Blood (2008) 111 (1): 183–189.

https://doi.org/10.1182/blood-2007-03-078543

Published: 2008

Includes: Supplemental data

Journal Articles

Understanding the Factor Va Cofactor Effect within Prothrombinase.

Michael Kalafatis, PhD, Michael A. Bukys, BS, Jamila Hirbawi, BS, Paul Y. Kim, BS, Melissa A. Barhoover, BS, Michael E. Nesheim, PhD

Blood (2007) 110 (11): 2700.

https://doi.org/10.1182/blood.V110.11.2700.2700

Published: 2007

Journal Articles

Factor Va Cofactor Activity Is Dependent on the Interaction of Prothrombin with the Membrane Surface.

Michael A. Bukys, BS, Tivadar Orban, BS, Paul Y. Kim, BS, Michael E. Nesheim, PhD, Michael Kalafatis, PhD

Blood (2007) 110 (11): 2702.

https://doi.org/10.1182/blood.V110.11.2702.2702

Published: 2007

Journal Articles

The Interaction of Prothrombin and Its Activation Products with Platelets.

John A. Samis, PhD, Reginald P. Manuel, BSc, Michael E. Nesheim, PhD

Blood (2006) 108 (11): 1514.

https://doi.org/10.1182/blood.V108.11.1514.1514

Published: 2006

Journal Articles

The Natural History of the Neutrophil Elastase and Coagulation Factor Response to E.coli in a Baboon Model of E.coli/Sepsis Suggests That Elevated Neutrophil Elastase Activity Is Sustained Regardless of Outcome in Clinical Sepsis.

John A. Samis, PhD, Kenneth A. Stewart, BSc, Fletcher B. Taylor, MD, Daniel J. Fournier, BSc, Michael E. Nesheim, PhD

Blood (2006) 108 (11): 1609.

https://doi.org/10.1182/blood.V108.11.1609.1609

Published: 2006

Journal Articles

Controlling the Pathway for Prothrombin Activation by Prothrombinase.

Michael A. Bukys, BS, Paul Y. Kim, BS, Michael E. Nesheim, Ph.D., Michael Kalafatis, Ph.D.

Blood (2006) 108 (11): 1695.

https://doi.org/10.1182/blood.V108.11.1695.1695

Published: 2006

Journal Articles

Exposure of Anion Binding Exosite I of Thrombin Is Required and Sufficient for Timely Cleavage and Activation of Factor V and Factor VIII.

Michael A. Bukys, BS, Tivadar Orban, BS, Paul Y. Kim, Michael E. Nesheim, PhD, Michael Kalafatis, PhD

Blood (2005) 106 (11): 1951.

https://doi.org/10.1182/blood.V106.11.1951.1951

Published: 2005

Journal Articles

Uptake of Factor V by Megakaryocytes Requires a Specific Factor V Receptor Linked to a Low-Density Lipoprotein Receptor-Related Protein.

Beth A. Bouchard, PhD, Natalie T. Meisler, PhD, Michael E. Nesheim, PhD, Paula B. Tracy, PhD

Blood (2005) 106 (11): 688.

https://doi.org/10.1182/blood.V106.11.688.688

Published: 2005

Journal Articles

A Rapid and Sustained Increase in Neutrophil Elastase Levels Correlates Temporally with Decreased Coagulation Factor Activity during E.coli-Sepsis in Baboons.

John A. Samis, PhD, Kenneth A. Stewart, Fletcher B. Taylor, Jr, MD, Michael E. Nesheim, PhD

Blood (2004) 104 (11): 1032.

https://doi.org/10.1182/blood.V104.11.1032.1032

Published: 2004

Journal Articles

A New Functional Coagulation Assay for Measurement of Total Factor V Activity in Human Plasma and Its Application to Samples from Patients with Disseminated Intravascular Coagulation.

John A. Samis, PhD, Kenneth A. Stewart, Cheng Hock Toh, MD, Colin Downey, Michael E. Nesheim, PhD

Blood (2004) 104 (11): 2983.

https://doi.org/10.1182/blood.V104.11.2983.2983

Published: 2004

Journal Articles

Cofactor Directed Catalysis.

Michael A. Bukys, BS, Paul Kim, BS, Melissa A. Blum, BS, Michael E. Nesheim, PHD, Michael Kalafatis, PHD

Blood (2004) 104 (11): 1715.

https://doi.org/10.1182/blood.V104.11.1715.1715

Published: 2004

Journal Articles

A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels

Geert-Jan Brouwers, Hans L. Vos, Frank W. G. Leebeek, Saskia Bulk, Mark Schneider, Michael Boffa, Marlys Koschinsky, Nico H. van Tilburg, Michael E. Nesheim, Rogier M. Bertina, Encarnación B. Gómez Garcı́a

Blood (2001) 98 (6): 1992–1993.

https://doi.org/10.1182/blood.V98.6.1992

Published: 2001

Journal Articles

Proteolytic processing of human coagulation factor IX by plasmin

John A. Samis, Gillian D. Ramsey, John B. Walker, Michael E. Nesheim, Alan R. Giles

Blood (2000) 95 (3): 943–951.

https://doi.org/10.1182/blood.V95.3.943.003k34_943_951

Published: 2000

Journal Articles

Neutrophil Elastase Cleavage of Human Factor IX Generates an Activated Factor IX-Like Product Devoid of Coagulant Function

John A. Samis, Eunice Kam, Michael E. Nesheim, Alan R. Giles

Blood (1998) 92 (4): 1287–1296.

https://doi.org/10.1182/blood.V92.4.1287

Published: 1998

Journal Articles

The Suicide Substrate Reaction Between Plasminogen Activator Inhibitor 1 and Thrombin Is Regulated by the Cofactors Vitronectin and Heparin

Marja van Meijer, Annelies Smilde, Guido Tans, Michael E. Nesheim, Hans Pannekoek, Anton J.G. Horrevoets

Blood (1997) 90 (5): 1874–1882.

https://doi.org/10.1182/blood.V90.5.1874

Published: 1997

NARROW

Solulin increases clot stability in whole blood from humans and dogs with hemophilia

The Role of Amino Acids 700–701 of the Factor Va Heavy Chain During Prothrombin Activation by Factor Xa

The Kinetics of Activated Thrombin-Activatable Fibrinolysis Inhibitor with Respect to Plasminogen Binding Site Removal From Fibrin Degradation Products.

The Role of Lysine Residues 42, 43, and 44 in the Activation Peptide Region of TAFI in Its Activation by the Thrombin-Thrombomodulin Complex.

The Effects of Activated Protein C, Heparin, and Antithrombin On Thresholding Behaviour in Prothrombin Activation by Prothrombinase.

Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis

Understanding the Factor Va Cofactor Effect within Prothrombinase.

Factor Va Cofactor Activity Is Dependent on the Interaction of Prothrombin with the Membrane Surface.

The Interaction of Prothrombin and Its Activation Products with Platelets.

The Natural History of the Neutrophil Elastase and Coagulation Factor Response to E.coli in a Baboon Model of E.coli/Sepsis Suggests That Elevated Neutrophil Elastase Activity Is Sustained Regardless of Outcome in Clinical Sepsis.

Controlling the Pathway for Prothrombin Activation by Prothrombinase.

Exposure of Anion Binding Exosite I of Thrombin Is Required and Sufficient for Timely Cleavage and Activation of Factor V and Factor VIII.

Uptake of Factor V by Megakaryocytes Requires a Specific Factor V Receptor Linked to a Low-Density Lipoprotein Receptor-Related Protein.

A Rapid and Sustained Increase in Neutrophil Elastase Levels Correlates Temporally with Decreased Coagulation Factor Activity during E.coli-Sepsis in Baboons.

A New Functional Coagulation Assay for Measurement of Total Factor V Activity in Human Plasma and Its Application to Samples from Patients with Disseminated Intravascular Coagulation.

Cofactor Directed Catalysis.

A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels

Proteolytic processing of human coagulation factor IX by plasmin

Neutrophil Elastase Cleavage of Human Factor IX Generates an Activated Factor IX-Like Product Devoid of Coagulant Function

The Suicide Substrate Reaction Between Plasminogen Activator Inhibitor 1 and Thrombin Is Regulated by the Cofactors Vitronectin and Heparin

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only